BioHarvest Sciences Cash on Hand 2020-2024 | BHST

BioHarvest Sciences cash on hand from 2020 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
BioHarvest Sciences Annual Cash on Hand
(Millions of US $)
2023 $5
2022 $2
2021 $4
2020 $2
2019 $1
2019 $1
2018 $1
BioHarvest Sciences Quarterly Cash on Hand
(Millions of US $)
2024-06-30 $5
2024-03-31 $3
2023-12-31 $5
2023-09-30 $2
2023-06-30 $2
2023-03-31 $0
2022-12-31 $2
2022-09-30 $2
2022-06-30 $1
2022-03-31 $1
2021-12-31 $4
2021-09-30 $7
2021-06-30 $4
2021-03-31 $6
2020-12-31 $2
2020-09-30 $3
2020-06-30 $2
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31 $1
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.098B $0.013B
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00